| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 36473 |
|
2,075 |
2,019 |
$755K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
10,430 |
10,365 |
$653K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,937 |
21,778 |
$472K |
| 36465 |
|
508 |
494 |
$263K |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
1,344 |
1,337 |
$249K |
| 93229 |
|
804 |
800 |
$166K |
| J2785 |
Injection, regadenoson, 0.1 mg |
3,778 |
3,761 |
$157K |
| 93970 |
|
3,170 |
3,159 |
$143K |
| 93000 |
|
14,201 |
13,731 |
$140K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,133 |
3,124 |
$112K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,157 |
2,152 |
$102K |
| 93015 |
|
1,757 |
1,755 |
$73K |
| 93880 |
|
1,478 |
1,474 |
$57K |
| 93925 |
|
1,941 |
1,928 |
$52K |
| 78492 |
|
486 |
486 |
$50K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
2,354 |
2,348 |
$47K |
| 93971 |
|
1,181 |
1,177 |
$37K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,516 |
4,323 |
$32K |
| 93297 |
|
3,177 |
3,133 |
$11K |
| 93017 |
|
1,810 |
1,800 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
938 |
938 |
$8K |
| 93016 |
|
1,976 |
1,966 |
$6K |
| 93295 |
|
525 |
523 |
$6K |
| 93228 |
|
813 |
802 |
$5K |
| 93294 |
|
982 |
976 |
$5K |
| 93018 |
|
2,134 |
2,123 |
$5K |
| 99233 |
Prolong inpt eval add15 m |
139 |
137 |
$4K |
| 99223 |
Prolong inpt eval add15 m |
80 |
76 |
$4K |
| 93296 |
|
315 |
311 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,192 |
1,165 |
$3K |
| 99152 |
|
499 |
478 |
$2K |
| 93224 |
|
29 |
29 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
580 |
572 |
$2K |
| 37252 |
|
29 |
27 |
$2K |
| 75716 |
|
200 |
185 |
$1K |
| 93280 |
|
208 |
205 |
$1K |
| 93307 |
|
38 |
38 |
$1K |
| 93289 |
|
125 |
124 |
$1K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
342 |
340 |
$1K |
| 93458 |
|
26 |
26 |
$914.00 |
| 80061 |
Lipid panel |
635 |
628 |
$894.73 |
| 80053 |
Comprehensive metabolic panel |
772 |
753 |
$882.22 |
| 93290 |
|
234 |
227 |
$818.53 |
| 93284 |
|
27 |
26 |
$394.96 |
| 93784 |
|
13 |
13 |
$317.32 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
345 |
315 |
$275.17 |
| 37253 |
|
28 |
26 |
$270.27 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
37 |
35 |
$182.50 |
| 99153 |
Mod sedat endo service >5yrs |
168 |
154 |
$153.46 |
| 93288 |
|
76 |
75 |
$144.27 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
33 |
32 |
$111.88 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
181 |
166 |
$88.03 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
110 |
99 |
$13.05 |
| 85347 |
|
213 |
198 |
$9.27 |
| 37229 |
|
105 |
96 |
$0.00 |
| 0296T |
|
13 |
13 |
$0.00 |
| 0298T |
|
13 |
13 |
$0.00 |
| 1123F |
|
191 |
184 |
$0.00 |
| 1111F |
|
496 |
489 |
$0.00 |
| 80047 |
|
30 |
28 |
$0.00 |